Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00572416

Completed

Fatigue in Breast Cancer: A Behavioral Sleep Intervention

Breast Cancer
NCT05729451

Completed

Change in Cardiorespiratory Fitness and Breast Cancer Incidence and Mortality

Occupational Health | Cardiorespiratory Fitness | Cancer of Breast
NCT05665894

Completed

Vacuum-Assisted Evacuation (VAE) Of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries And Percutaneous Procedures: a Retrospective Analysis

Breast Cancer | Breast Diseases | Breast Haematoma
NCT01535066

Completed

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Pain | Breast Cancer
NCT01711710

Active, not recruiting

Clinical Trial to Evaluate the Safety and Efficacy of Breast Implant

Breast Cancer
NCT04795778

Unknown

The Validity and Reliability of FIT-HaNSA in Breast Cancer Patients

Breast Cancer | Upper Extremity Dysfunction | FIT-HaNSA
NCT03066947

Completed

SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer

Breast Neoplasm | Breastcancer
NCT04479098

Completed

Effects of Training and Detraining on Postmenopausal Breast Cancer Survivors

Breast Neoplasm Female
NCT00892515

Completed

Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer

Breast Cancer | Healthy, no Evidence of Disease
NCT01091168

Completed

Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

Breast Cancer | Metastases
NCT03674515

Unknown

Study of Program Interest "Bouge" to Improve the Daily Physical Activity in Processings Treatment of Non-metastatic Breast Cancer (BOUGE CANCER)

Breast Cancer | Physical Activity | Mobile Health Apps
NCT00097487

Completed

A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane

Breast Cancer | Metastases
NCT03349177

Unknown

Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy

Breast Cancer | Neoadjuvant Chemotherapy | Pathological Complete Response
NCT01495650

Completed

Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment (APAD)

Breast Cancer
NCT00425776

Completed

Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture

Breast Cancer | Postmenopause
NCT01204957

Completed

Brown Seaweed as a Breast Cancer Preventive

Breast Cancer
NCT01893944

Completed

Applicability of Video Games and Vibrational Therapy in Reducing Pain Secondary to Breast Cancer

Pain
NCT02041364

Unknown

Biomarkers of Fatigue Related to Adjuvant Chemotherapy for Breast Cancer

Breast Cancer | Fatigue
NCT00513916

Completed

Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

Breast Cancer | Healthy, no Evidence of Disease
NCT00914043

Withdrawn

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

Breast Cancer | Fatigue
NCT01195298

Unknown

Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer

Breast Cancer | Metastasis
NCT00801476

Unknown

Pre-operative Magnetic Resonance Imaging (MRI) in Young Breast Cancer Patients

Breast Cancer | Magnetic Resonance Imaging | Preoperative MRI
NCT00099281

Terminated

DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer

Breast Cancer | Metastases
NCT07610525

Not yet recruiting

Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial

Triple Negative Breast Cancer | Phase 2 | Blood and Image Guided | Optimization of Neoadjuvant Therapy
NCT07285993

Not yet recruiting

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

Breast Cancer | Metastatic Invasive Lobular Breast Cancer
NCT06374459

Recruiting

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
NCT03854617

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
NCT03711877

Recruiting

Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study) (COHAIR)

Primary Breast Cancer
NCT02091960

Completed

A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

Advanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)
NCT04784182

Terminated

Anti-anxiety Biotics for Breast Cancer Survivors (ABBCS)

Breast Cancer Female | Anxiety Generalized
NCT03162133

Completed

Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy
NCT02269696

Withdrawn

The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients

Breast Cancer
NCT04348747

Recruiting

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain
NCT05086705

Completed

EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer

Hot Flashes | Breast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ
NCT05364450

Completed

Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors

Breast Cancer | Anxiety | Breast Neoplasm | Breast Carcinoma | Fear | Cancer of Breast | Malignant Tumor of Breast | Malignant Neoplasm of Breast | Mammary Cancer | Mammary Neoplasms, Human
NCT07042568

Completed

The Effect of Education Given on Preventing Mouth Ulcers in Women With Breast Cancer

Chemotherapy | Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT00807859

Completed

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Cancer | Breast Cancer | Breast Neoplasms | Metastatic Cancer | Breast Tumors | Solid Tumors | Oncology | Tumors | Metastases | Locally Recurrent and Metastatic Breast Cancer
NCT04296929

Unknown

The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema.

Breast Cancer | Lymphedema | Lymphedema of Upper Arm
NCT02159274

Completed

Shoulder Disability and Late Symptoms Following Oncoplastic Breast Surgery

Breast Cancer | Carcinoma in Situ of the Breast
NCT01936961

Withdrawn

Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors (I-CREST)

Metastatic Non-Small Cell Lung Cancer | Metastatic Colon Cancer | Metastatic Triple Negative Breast Cancer
NCT05447988

Recruiting

Motiva Flora Tissue Expander PMCF

Breast Cancer | Breast Tissue Accessory
NCT02986360

Completed

Informed Implementation of Breast Density Reporting

Breast Density, Breast Cancer Prevention
NCT03881605

Active, not recruiting

MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC (SYMPToM)

Breast Neoplasm | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Brain Metastases
NCT01705340

Terminated

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Adenocarcinoma of the Gastroesophageal Junction | Recurrent Breast Cancer | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer
NCT03210311

Completed

Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema (DEARLY)

Breast Cancer | Lymphedema of Upper Arm | Diagnoses Disease
NCT04934098

Completed

Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema

Breast Neoplasms | Lymphedema of Upper Arm | Breast Cancer Related Lymphedema | Lymphedema, Secondary
NCT03970967

Terminated

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.Pathology
NCT04881604

Completed

Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema

Breast Neoplasms | Lymphedema of Upper Arm | Breast Cancer Related Lymphedema | Lymphedema, Secondary
NCT02457910

Terminated

Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

Stage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast Carcinoma
NCT06837792

Recruiting

Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer

Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative)

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations